New “old” polylactides for tissue engineering constructions
- Авторлар: Antonov E.N.1, Bukharova T.B.2, Dunaev A.G.1, Krotova L.I.1, Nifant’ev I.E.3, Popov V.K.1, Shlyakhtin A.V.3
-
Мекемелер:
- Institute of Photon Technologies, Crystallography and Photonics Federal Scientific Research Center
- Medical Genetic Scientific Center
- Moscow State University
- Шығарылым: Том 8, № 5 (2017)
- Беттер: 704-712
- Бөлім: Materials for Ensuring Human Vital Activity and Environmental Protection
- URL: https://journals.rcsi.science/2075-1133/article/view/206816
- DOI: https://doi.org/10.1134/S2075113317050033
- ID: 206816
Дәйексөз келтіру
Аннотация
New methods for the synthesis of aliphatic polyesters were proposed and realized with highly effective and low-toxic 1,5,7-triazabicyclo[4.4.0]decene-5 and (2,6-di-tert-butyl-4-methylphenoxy)-butyl-magnesium as catalysts and ethanol as an initiator. The interaction processes between D,L-polylactides of different molecular weights, obtained through these methods, and supercritical carbon dioxide were studied to provide “soft and dry” formation (without high temperatures and toxic organic solvents) of highly porous (up to 90 vol %) bioresorbable matrices for tissue engineering constructions. The chemical structure, molecular weight characteristics, morphology, cytotoxicity, and matrix properties of the samples synthesized from D,L-polylactides were studied with nuclear magnetic resonance spectroscopy, gel permeation chromatography, scanning electron microscopy, colorimetric testing to estimate the metabolic activity of cells (MTT test), and coloration with a vital fluorescent dye of in vitro cultures of multipotent stromal cells of human adipose tissue. A comparative analysis for biocompatibility of these matrices with control samples made from “medical grade” polylactide analog produced industrially indicates that the materials developed can be recommended for tissue engineering.
Авторлар туралы
E. Antonov
Institute of Photon Technologies, Crystallography and Photonics Federal Scientific Research Center
Хат алмасуға жауапты Автор.
Email: e_n_antonov@mail.ru
Ресей, Troitsk, Moscow, 142190
T. Bukharova
Medical Genetic Scientific Center
Email: e_n_antonov@mail.ru
Ресей, Moscow, 115478
A. Dunaev
Institute of Photon Technologies, Crystallography and Photonics Federal Scientific Research Center
Email: e_n_antonov@mail.ru
Ресей, Troitsk, Moscow, 142190
L. Krotova
Institute of Photon Technologies, Crystallography and Photonics Federal Scientific Research Center
Email: e_n_antonov@mail.ru
Ресей, Troitsk, Moscow, 142190
I. Nifant’ev
Moscow State University
Email: e_n_antonov@mail.ru
Ресей, Moscow, 119991
V. Popov
Institute of Photon Technologies, Crystallography and Photonics Federal Scientific Research Center
Email: e_n_antonov@mail.ru
Ресей, Troitsk, Moscow, 142190
A. Shlyakhtin
Moscow State University
Email: e_n_antonov@mail.ru
Ресей, Moscow, 119991
Қосымша файлдар
